Ezetimibe Olpha

Medicinal product

(Invented) name

Ezetimibe Olpha

Active substance (s)

Ezetimibas

Strength

10 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C10AX09, Ezetimibe

Marketing authorisation holder

Olpha AS, Latvija

Date of authorisation

2026-05-13

Date of renewal

Documents

6021_pakuotes lapelis_2026-05-13.docx

6021_Ezetimibe Olpha.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

LV/H/0291/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Ezetimibas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120821	106929	1106929	lizdinė plokštelė	N28 (2×14)		Receptinis	LT/1/26/6021/001	Netiekiama	-	-	No	-	-
120822	106930	1106930	lizdinė plokštelė	N56 (4×14)		Receptinis	LT/1/26/6021/002	Netiekiama	-	-	No	-	-
120823	106931	1106931	lizdinė plokštelė	N100 (10×10)		Receptinis	LT/1/26/6021/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-05-13	Registruotas